Abstract：
The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use.
A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered.
Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients\' interests.
A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered.
Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients\' interests.
摘要：
冠状动脉血运重建指南取代了2011年冠状动脉旁路移植术和2011年和2015年经皮冠状动脉介入治疗指南。提供以患者为中心的方法，指导临床医生治疗接受冠状动脉血运重建的重大冠状动脉疾病患者，并提供支持文件，鼓励他们使用。
从2019年5月至2019年9月进行了全面的文献检索，包括研究，reviews,以及PubMed以英文发表的关于人类受试者的其他证据，EMBASE,科克伦合作组织,CINHL完成，和其他相关数据库。其他相关研究，到2021年5月出版，也被考虑。
冠状动脉疾病仍然是全球发病率和死亡率的主要原因。冠状动脉血运重建是治疗冠心病患者的重要治疗选择。2021年冠状动脉血运重建指南根据当代证据为这些患者的治疗提供了建议。这些建议提出了一种基于证据的方法来管理正在考虑进行冠状动脉血运重建的冠心病患者。旨在提高护理质量并符合患者的利益。
从2019年5月至2019年9月进行了全面的文献检索，包括研究，reviews,以及PubMed以英文发表的关于人类受试者的其他证据，EMBASE,科克伦合作组织,CINHL完成，和其他相关数据库。其他相关研究，到2021年5月出版，也被考虑。
冠状动脉疾病仍然是全球发病率和死亡率的主要原因。冠状动脉血运重建是治疗冠心病患者的重要治疗选择。2021年冠状动脉血运重建指南根据当代证据为这些患者的治疗提供了建议。这些建议提出了一种基于证据的方法来管理正在考虑进行冠状动脉血运重建的冠心病患者。旨在提高护理质量并符合患者的利益。
